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Background: Microbial infections and resulting inflammation and oxidative stress are common pathogenesis of
gastrointestinal tract (GIT) disorders. In South Africa, several species of the genus Maytenus are used in traditional
medicine to treat various infectious diseases. Most of the previous work on this genus was focused on nonpolar
extracts from the root and bark. In this study, leaf extracts of polar extracts of Maytenus peduncularis, Maytenus
procumbens, Maytenus senegalensis and Maytenus undata were evaluated for antimicrobial, anti-inflammatory and
antioxidant activities to determine their efficacy as therapeutic agents in GIT disorders.
Methods: Phenolic-enriched leaf extracts and fractions were prepared by extracting with acidified 70% methanol
and solvent-solvent fractionation. The activities of the fractions against Staphylococcus aureus, Pseudomonas
aeruginosa, Escherichia coli and Enterococcus faecalis as well as clinical isolates of Aspergillus fumigatus, Candida
albicans and Cryptococcus neoformans were determined using a serial microplate dilution method. Antioxidant
activities were determined using 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2'-azinobis(3-ethylbenzthiazoline-6-
sulphonic acid) (ABTS), hydroxyl (OH) radical scavenging and linoleic acid peroxidation inhibitory assays. The
phenolic composition as well as the cytotoxicity against Vero cell lines of the crude extracts was evaluated using
various standard protocols.
Results: The antimicrobial activities were concentrated in the non-polar fractions of hexane, dichloromethane and
ethyl acetate (MICs 19–312 μg/ml). The crude extracts and polar fractions (butanol and water) had moderate to
poor antimicrobial activity (MICs 312 to above 2500 μg/ml). The crude extracts and polar fractions had good
antioxidant activity (EC50 values varied from 1.22 to 607 μg/ml, 1.71 to 312 μg/ml and 23 to 284 μg/ml for DPPH,
ABTS and OH respectively. Linoleic acid peroxidation inhibition EC50 values of the crude extracts ranged between
27 and 39 μg/ml with relatively low toxicity against Vero cell lines (IC50 values 87 to 187 μg/ml). Fractionation of a
crude extract with low activity could lead to fractions with more potent activity.
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Conclusion: This study justifies the traditional use of leaf crude extracts and fractions from these four plants to
remedy gastrointestinal disorders resulting from infection, inflammation and oxidative stress complications. The
study also provides rationale for the use of leaf extracts with same beneficial effects in place of unsustainable root
and bark harvest.
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The gastrointestinal tract (GIT) is a long tube with huge
epithelial surface area through which nutrients and fluid
passes for digestion and absorption [1]. The basic se-
quence of GIT is mouth, oesophagus, stomach, duode-
num, small intestine, large intestine, rectum, and the
anus, where wastes are eliminated [2]. A healthy GIT is
permanently populated with a diverse microbial commu-
nity, termed the microbiota, which is composed of over
300 different species of prokaryotic and eukaryotic mi-
croorganisms. The microbiota microbes exist in complex
commensal relationships within the host environment,
including the mucosa and luminal contents of the di-
gestive tract [3,4]. Infection of the GIT by pathogenic or
opportunistic (intestinal microbiota) microbes cause a
variety of intestinal disorders. The disorders may lead to
nausea, vomiting, diarrhoea, abdominal pain, intestinal
inflammation, bloating and flatulence, or systemic dis-
eases [5]. GIT infectious pathogens (bacteria, virus,
protozoa and rarely fungi) have a multitude of proven
and hypothetical mechanisms through which they can
induce various ailments.
Among the GIT disorders, diarrhoea is the most
prevalent and dangerous being a major cause of morbid-
ity and mortality worldwide [5]. Diarrhoea occurs when
secretory processes exceed the absorptive capacity of the
GIT through four identifiable mechanisms: (1) increased
secretion from mucosal; (2) decreased absorption (ions
and/or solutes and water); (3) altered motility; and
(4) increased permeability [6]. The flushing action of diar-
rhoea can be beneficial as it leads to removal of harmful
luminal contents, however, the resulting dehydration from
uncontrolled episode can become life threatening [4].
Mortality from infectious diseases in developed countries,
where there are low records of invasive infection is low
while in resource-constrained developing countries with
more cases of infective ailments, the death rate is high [7].
High prevalence of infectious diarrhoea in resource-
constrained countries where most people with immuno-
deficiency challenges live is associated with high poverty,
illiteracy level, lack of portable water, poor sanitation, un-
hygienic conditions, and inadequate control of vectors
and infection of reservoirs [8]. Diarrhoea caused by a var-
iety of definable pathogens (opportunistic infection) is alsoa common problem in human immunodeficiency virus
(HIV)-infected patients with CD4+ counts <200 cells/μl
or patients with advanced human immunodeficiency
virus (AIDS) [9]. The emergence multi-drug resistance
strains to antibiotics are compounding the problems of
treatment of infectious diseases in immunocompro-
mised patients [10].
A harmful stimulus in GIT including endotoxins, in-
fections and cytotoxins stimulates macrophages and
monocytes to secrete several pro-inflammatory cytokines
such as tumour necrosis factor-α, interleukin-1, and
interleukin-6 [11]. Nonspecific inflammation induced by
these irritants can cause intestinal fluid accumulation
which may result in inflammatory diarrhoea [4]. Cyto-
toxic effects on GIT may lead to villus atrophy, decrease
in the digestive and absorption capacities of the intes-
tine, generating a malabsorption components. Microbial
fermentation of undigested and non-absorbed nutrients
reaching the colon, leads to accumulation of osmotically
active solutes causing osmotic diarrhoea [7]. Inflamed
GIT lead to persistent changes in enteric nervous sys-
tem, the intrinsic innervation of the bowel which con-
trols virtually all intestinal functions (motility, secretion,
blood flow, mucosal growth and aspects of the local im-
mune system), and smooth muscle function. The result-
ant colonic dysmotility, hypersensitivity, and dysfunction
accompany GIT inflammation give rise to diarrhea,
cramping, and pain [7].
Cytokines from activate inflammatory cells can release
large amounts of toxic oxygen (peroxide anion, hydrogen
peroxide and hypochlorous acid) and nitrogen species,
proteases, arachidonic acid metabolites (prostaglandins
from cyclooxygenase pathways and leukotrienes from
lipoxygenase). The processes cause cellular injury by sev-
eral mechanisms including peroxidation of membrane
lipids and oxidative damage of proteins or DNA. The
mechanisms of lipid peroxidation involved free radical
or other reactive oxygen species chain reactions to
produce toxic products which attack and damage bio-
logical molecules [11]. Oxidative species are not dor-
mant products of inflammation, but active molecules in
the pathogenesis of inflammatory processes. Gastrointes-
tinal infections are potent stimuli of intestinal mem-
brane lipids peroxidation as an important pathogenic
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tions of reactive species and depleted inherent antioxi-
dant defences in intestinal mucosa are involved in a
cycle of infection, malabsorption, and malnutrition [13].
Superoxide dismutase and catalase are endogenous
antiperoxidative enzymes that protect the cellular con-
stituents against oxidative damage. However, the efficacy
of the endogenous antioxidant defence system may be
impaired during inflammation [14]. High antioxidative
activity and efficient inhibition of polyunsaturated fatty
acid peroxidation of GIT epithelial lipid by pharmaco-
logical agents including phytochemicals can significantly
counteracted oxidative stress and inflammation in this
common and chronic infectious disease.
Treatment of infectious diarrhoea typically targets the
specific pathogen causing the condition. Some therapies
that may be used include antimicrobial agents, such as cip-
rofloxacin (bacterial pathogens), such as amphotericin,
fluconazole (fungal pathogens) or antiprotozoal agents,
such as metronidazole (Giardia infection) or albendazole
(Encephalitozoon intestinalis). Causal pathogens of GIT
disorders are becoming resistant to drugs [15-17]. These
resistant pathogens have given rise to:
 Infections that would otherwise not have occurred.
 Increased frequency of treatment failures.
 Increased severity of infections [18].
Hence the search for more safe and effective antimicro-
bial compounds is important. Plant-based medicines have
been used for thousands of years in traditional systems of
health care to treat a wide range of ailments caused by mi-
crobial infections and resultant inflammatory/oxidative
stress complications. Search for plants with broad pharma-
cological activities, but of low toxicity has increasingly
gained importance in recent years. In southern Africa,
different plants species belonging to the genus Maytenus
are extensively used in traditional medicines to treat diar-
rhoea, stomach infections, pain and inflammation of the
digestive system, stomach cleansing, chest pain, and skin
diseases. The species include Maytenus accuminata (L.f.)
Loes [19], Maytenus heterophylla (Eckl. & Zeyh) Robson
[20], Maytenus peduncularis (Sond) Loes [21], Maytenus
procumbens (L.f.) Loes [22], Maytenus undata (Thunb)
Blakelock [23] and Maytenus senegalensis (Lam.) Exell (syn
Gymnosporia senegalensis (Lam.) Loes) [24-26].
Another important point to consider is that the use of
the root or bark stem of trees as medicinal component
could compromise the population of the native species.
Continuous exploitation of root or bark stem of trees is
not sustainable because removal of such parts leads to
plant death [23,27]. It is important to verify whether
other parts of the plant can have the same beneficial ef-
fects with lower toxicity. From the literature, root barkand stem bark of Maytenus are primarily used in trad-
itional medicines and the major focus of previous re-
search on the genus. However, there are reports of
various uses for the leaves [23,27]. In the Phytomedicine
Programme we evaluated and determined the biological
activities of tree leaf extracts for medicinal purposes
because of the sustainability of leaf harvest compared to
roots and stems.
In this study, we hypothesised that phytochemicals from
the leaf extracts of M. peduncularis, M. procumbens, M,
undata and M. senegalensis may not be be cytotoxic and
can provide protection against some enteroinvasive patho-
gens as well as sustain recovery of the epithelium by pro-
moting inflammatory and oxidative stress healing in
infectious diarrhoea. We investigated the rationale for the
use of the crude leaf extracts and fractions of various polar-
ities from the four Maytenus species as therapeutic and
preventative agents, at least in infectious diarrhoea, and
perhaps also in diarrhoea associated with acute or chronic
inflammation/oxidative damage of the gut.
Methods
Plant collection
The leaves of M. peduncularis, M. procumbens, M.
senegalensis (syn Gymnosporia senegalensis (Lam.) Loes)
and M. undata were collected by courtesy of Mrs Lita
Pauw from the samples kept in the Phytomedicine
Programme plant collection. The plant material was
originally identified and authenticated by Ms. Lorraine
Middleton and Magda Nel at the University of
Pretoria Botanical Garden. The voucher specimen
numbers in the HWG Schweikert Herbarium were
PRU 76382, PRU 77119, PRU 114717, and PRU
18576 for M. peduncularis, M. procumbens, M.
senegalensis (syn Gymnosporia senegalensis) and M
undata respectively.
Preparation of extracts
The extraction process to obtain crude extracts and frac-
tions with varying polarities is presented in Figure 1 as
described by Naczk and Shahidi [28] with some modifi-
cations. The ground leaf materials (20 g) were extracted
with mixture of acidified 70% acetone and n-hexane.
The dried polar samples (crude extracts, butanol and
residual fractions) were dissolved in 70% acetone or 25%
methanol in acetone solution while the non-polar
(hexane, ethyl acetate, and dichloromethane) fractions




Four standard bacterial strains of the most important
nosocomial pathogens including two Gram positive
Plant material (20g) Simultaneous extraction and fractionation 
with mixture of acidified 70% acetone (200
ml) and n-hexane (200 ml).









Portion A (freeze dried
as crude extract)
Portion B (Liquid-liquid 
partition using solvent of 
different polarities)
Phytochemical evaluation of phenolic 
components (total phenolics, non-
tannin phenolics, total tannins, 
condensed tannin, gallotannin, total 
flavonoids, flavonol, anthocyanin) 
Figure 1 Optimized phenolic-enriched extraction process, fractionation and, analysis of the extract phenolic content.
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coccus faecalis (ATCC 29212)), and two Gram negative
(Escherichia coli (ATCC 25922), Pseudomonas aeruginosa
(ATCC 27853) were used in this work. The bacteria are
commonly involved in GIT infections with resultant
inflammation and diarrhoeal symptoms [29-31]. Three
pathogenic and opportunistic fungal isolates were obtained
from the Bacteriology Laboratory, Department of Veterin-
ary Tropical Diseases, Faculty of Veterinary Science,
University of Pretoria and used as test organisms. These
fungi represent the different morphological forms of
fungi, namely yeasts (Candida albicans isolated from a
Goldian finch and Cryptococcus neoformans isolated
from a cheetah) and moulds (Aspergillus fumigatus iso-
lated from a chicken), all of which suffered from a sys-
temic mycosis. These fungi are the most common and
important opportunistic disease-causing fungi of animals
mainly urogenital, respiratory and gastrointestinal com-
plications [32-37].
Minimum inhibitory concentration (MIC)
Minimum inhibitory concentration (MIC), a quantitative
end point measurement of the concentration of crude
leaf extracts (acidified 70% acetone) and fractions of the
4 medicinal plants that halt microbial growth under
visible threshold after 18 to 24 h were evaluated [38].
The assay was carried out by broth serial micro
dilution assay using 96-well microtitre plate with
p-iodonitrotetrazolium violet (INT) added as growth
indicator [39].
For antibacterial test, bacterial cultures (Staphylococ-
cus aureus, 2.6 × 1012 cfu/ml; Enterococcus faecalis, 1.5 ×
1010 cfu/ml; Pseudomonas aeruginosa, 5.2 × 1013 cfu/ml;
Escherichia coli, 3.0 × 1011 cfu/m were sub-cultured from
Mueller Hinton (MH) agar plates with a 10% inoculum
inMueller Hinton broth (MHB) (bacteria) was grown
overnight. Microtitre plates were prepared by addition of100 μl of distilled sterilized water to each well. A 100 μl
aliquot of the test samples at a starting concentration of
10 mg/ml, positive controls (gentamicin) and negative
control (acetone) were added to the first well followed
by two fold serial dilutions. The final concentration of
test samples was 2500 μg/ml (first well) and 19 μg/ml
(last well). To each well, 100 μl of the bacterial cultures
was added. This 50% inoculum ensyured there was no
lag phase in the growth of the microorganism (39). The
plates were airtight sealed and incubated at 37°C under
100% relative humidity conditions overnight. Thereafter,
40 μl of 0.2 mg/ml INT solution was added to all inocu-
lated wells to determine growth inhibition of the
microbes. The bacterial growth inhibitions were ob-
served for 2 h at 30 min intervals after the addition of
INT [39].
For antifungal test, fungal cultures (Candida albicans,
2.5 × 106 cfu/ml; Aspergillus fumigatus, 8.1 × 106 cfu/ml
and Cryptococcus neoformans, 2.6 × 106 cfu/ml) were
sub-cultured from Sabouraud agar plates and with a 10%
inoculum in Sabouraud dextrose broth were grown
overnight. The MICs determined using the serial dilu-
tion assay [40] with some modifications involving the
addition of INT to the inoculated wells immediately be-
cause of the slower growth nature of fungi [41]. Ampho-
teric B and acetone were used as positive and negative
control respectively. The plates were airtight sealed and
incubated at 37°C for 36 h after which the fungal growth
inhibitions observed for 6 h at 1 h intervals.
Antioxidative assays
2, 2-Diphenyl-1-picrylhydrazyl (DPPH) radical scaven-
ging assay
The scavenging activity of crude extracts and fractions
was assessed as described by Brand-Williams et al.,
[40] based on the reduction of methanolic DPPH in pres-
ence of a hydrogen donating antioxidant with some
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violet coloured solution which has maximal absorption
at 516 nm changes to yellow on reduction. The free rad-
ical scavenger activity of the compound is proportional
to the colour change of DPPH. The methanolic solution
of DPPH (0.4 mg/ml, 160 μl) was dispensed from stock
and added to 40 μl ascorbic acid and trolox, 1.0–200 μg/
ml (positive controls), different concentrations of crude
extracts and fractions (3.9–500 μg/ml) or vehicle (an
equivalent amount of methanol in the absence of sub-
stance test). Thirty minutes later the absorbance was
measured at 516 nm using a Versamax microplate reader.
The analysis was carried out in triplicate, and the results
were expressed as percentage reduction of the initial
DPPH absorption in relation to the control group. The
concentration of extract that reduced DPPH colour by
50% (EC50) was determined.
2, 2’-azinobis (3-ethylbenzthiazoline-6-sulphonic acid)
(ABTS) radical scavenging assay
The ABTS radical scavenging capacity of the samples
was measured with modification to a 96-well microtitre
plate format [42]. ABTS radical was generated by
reacting 7 mM solution of ABTS and 2.45 mM solution
of potassium persulfate at room temperature for 12 h.
The ABTS radical stock solution was adjusted to 7.00 ±
0.02 at 734 nm before use. The test samples (40 μl) were
made in a concentration range of 0.3-250 μg/ml by two
fold serial dilutions and 160 μl of ABTS radical solution
was added. Absorbance was measured after 6 min at
734 nm. Trolox and ascorbic acid were used as positive
controls, methanol as negative control and extract
without ABTS as blank.
Hydroxyl radical scavenging assay
The hydroxyl radical scavenging activity of the extracts
was determined with some modifications [43]. The hy-
droxyl radical was generated by using the Fenton reac-
tion where 50 ml of ferrous chloride (8.0 mM), 80 ml of
hydrogen peroxide and 50 ml of distilled water, was
allowed to stand for 1 h. The mixture was filtered to re-
move the debris. Hydroxyl radical was determined by
mixing 120 μl of the hydroxyl radical solution with 66 μl
of the extracts followed by 14 μl of salicylic acid
(20 mM). The mixture was incubated for 30 min at 37°C
and absorbance read at 510 nm.
Linoleic acid peroxidation inhibitory assay
The inhibition by the extracts of lipid peroxidation was
determined according to the thiobarbituric acid method
[44] with some modifications. The Fenton reaction (Fe2++
H2O2→ Fe
3++OH·) was used to induce the linoleic acid
emulsion peroxidation [45]. In this assay, the aliquot
contain 2.5 ml of linoleic acid solution in methanol,150 μl of TRIS HCl, 50 μl of ascorbic acid, 500 μl of
extract (8.0-250 μg/ml) and 50 μl of FeSO4. The mixture
was incubated at 37°C for 60 min in the dark and the
reaction was terminated by adding 516 μl of 40%
trichloroacetic acid dissolved in 0.01% sodium hydrox-
ide solution. The MDA generated was measured by
adding 1.6 ml of thiobarbituric acid solution and the re-
action mixture heated at 95°C for 15 min. The absorb-
ance was recorded at 510 nm.
Cytotoxicity assay of the crude extracts against Vero cell
lines
Cytotoxicity of the extract was determined by the MTT
[3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium
bromide] assay [46] using a Vero African green monkey
kidney cell line. The cells were cultured in Minimal Essen-
tial Medium (MEM) Earle’s Base (Sigma), supplemented
with 2 mM L-glutamine, 16.5 mM NaHCO3 together with
0.1% gentamicin (Virbac) and 5% foetal calf serum (Sigma).
Confluent monolayer culture suspensions of the cells were
seeded into 96-well tissue culture microtitre plates at a
density of 2 × 103 cells per well and incubated for 24 h at
37°C in a 5% CO2 incubator. The MEM was removed from
the cells, and extracts at various concentrations, positive
control (berberine chloride (Sigma)) and negative controls
were added and incubated for 5 days. The cells were ob-
served using an inverted microscope to check for cyto-
pathic effect from the extract. The cell proliferation and
viability was quantified by addition of 30 μl of a 5 mg/ml
solution of MTT in PBS to each well and incubation for an-
other 4 h at 37°C. The medium was carefully removed from
the wells without disturbing the MTT concentrate and
washed twice with PBS. The liquid was aspirated from
the cells and 50 μl of DMSO was added to each well
to dissolve the crystallized MTT formazan. The
amount of reduced MTT was measured as absorb-
ance at 570 nm using a Versamax microtitre plate
reader. The results were expressed as a percentage
growth of the control cells and IC50 values were cal-
culated (Table 1).
Phytochemical analysis
Determination of total phenolic constituents of the
extracts The total phenolic constituents of the extracts
were determined using Folin-Ciocalteau method with
some modifications [47]. The crude extracts (50 μl) at
concentration of 1:1 (mg:ml/w:v) plant material and
extracting solvent was mixed with 500 μl distilled water,
250 μl of commercial Folin-Ciocalteau reagent diluted
with distilled water (1:1) and 1250 μl of 20% sodium
carbonate solution. Absorbance of the mixture was
recorded at 725 nm after incubation for 40 min. The
concentration of polyphenols (expressed as mg Gallic /g
Table 1 Cytotoxicity of the acidified 70% acetone extracts
Test samples Cytotoxicity (IC50 (μg/ml)) Lipid peroxidation inhibition (LC50 (μg/ml)) Lipoxygenase inhibition (LL50 (μg/ml)
Maytenus peduncularis 89.41 ± 16.6 39.84 ± 5.52 44.15 ± 5.60
Maytenus procumbens 187.71 ± 19.92 34.21 ± 1.63 117.93 ± 36.50
Maytenus senegalensis 87.62 ± 3.02 27.21 ± 2.3 115.80 ± 20.11
Maytenus undata 99.17 ± 11.88 33.70 ± 0.85 50.92 ± 25.70
Berberine (positive control) 4.74 ± 0.41
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standard curve (0.0019-0.25 mg/ml gallic acid) prepared
at the same time using the following equation:
Absorbance ¼ 4:9022  TP mg GAEð Þ; R2
¼ 0:9804
Determination of total tannin content
The total tannin content of the extracts was determined
by using the polyvinylpyrrolidone (PVPP) binding method
[47]. The tannin-binding mixtures were prepared by
mixing 100 mg of PVPP, 1.0 ml of distilled water and
1.0 ml of tannin-containing extracts in a centrifuge tube.
The mixtures were thoroughly mixed by vortexing and
kept at 4°C for 15 min. The mixture was thawed and fil-
tered using Whatman number 1 filter paper to remove the
bound tannin. The filtrate (100 μl) was dispensed into a
test tube and the phenolic content determined as de-
scribed above. Non-tannin phenolic composition was de-
termined from the standard curve of catechin expressed
as catechin equivalent in mg/g dry material. The tannin
content was calculated as the difference between the total
phenolic and non-phenolic content of the extracts because
the tannin was bound and precipitated by PVPP.
Determination of proanthocyanidin content
The proanthocyanidin content of the extracts was deter-
mined using the butanol-HCl assay [47]. The extract
(500 μl) was dispensed into a test tube and diluted to
10 ml with 70% acetone. 3.0 ml of 95/5 butanol/HCl re-
agent and 100 μl of 2% ferric ammonium sulphate in
2 N HCl were added. The test tubes were loosely cov-
ered and heated in a boiling water bath for 50 min. The
absorbance was recorded at 550 nm after the tubes and
contents were cooled to room temperature. Absorbance
of the unheated mixture was used as a blank.
Determination of condensed tannin content
The condensed tannin content of the extracts was deter-
mined using the vanillin/HCl assay [48]. To 0.5 ml of the ex-
tract measured into a test tube, 3 ml of vanillin reagent
containing 4% concentrated HCl and 0.5% of vanillin in
methanol was added. The mixture was allowed to stand for
15 min. The absorbance was recorded at 500 nm againstmethanol as a blank. The concentration of condensed tannin
in the extracts expressed as catechin equivalent (CE)/g dry
plant material was calculated using the following equation:
Absorbance ¼ 0:1791  CT mg CEð Þ þ 0:0504; R2
¼ 0:9440:
Determination of hydrolysable tannin (gallotannin)
The gallotannin content of the extracts was determined
with the potassium iodate assay [49]. To 3 ml of the
extract, 1 ml of saturated solution of potassium iodate
was added and allowed to stand at room temperature for
40 min. The absorbance was read at 550 nm. A standard
curve was prepared using gallic acid under the same
conditions as the extracts and results expressed as gallic
acid equivalent (GAE)/g dry plant material was calcu-
lated using the following equation:
Absorbance ¼ 0:8264  GT mg GAEð Þ
þ 0:0392; R2
¼ 0:9155:
Determination of total flavonoids and flavonols
The total flavonoid content of the extracts was deter-
mined by the aluminium chloride method with some
modifications [50]. Briefly 100 μl of the extract was
mixed with 100 μl of 20% AlCl3 and two drops of glacial
acetic acid. The mixture was diluted with methanol to
3000 μl. Absorbance was read at 415 nm after 40 min.
Blank samples were prepared with the extract without
AlCl3. Standard curve was prepared using quercetin
(3.9-500 μg/ml) in methanol under the same conditions.
The concentration of flavonoids was expressed as mg
quercetin equivalent/g of dry plant material was calcu-
lated using the following equation:
Absorbance ¼ 0:9747  FT mg quercetinð Þ;R2
¼ 0:9846:
The flavonol content of the extracts was determined
by the aluminium chloride method [50] with some mod-
ifications. Extract (1 ml) was mixed with 1 ml of 20 mg/ml
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standard curve was prepared using quercetin (0.0019-
0.0312 mg/ml) in methanol under the same conditions.
Absorbance was read at 440 nm after 2.5 h. The concen-
tration of flavonol was expressed as mg quercetin
equivalent/g of dry plant material was calculated using
the following equation:
Absorbance ¼ 34:046  FLL mg quercetinð Þ; R2
¼ 0:9853:
Lipoxygenase inhibitory assay
The soybean 15-lipoxygenase (LOX) enzyme inhibition
was measured in borate buffer (0.2 M, pH 9) by follow-
ing the increase in absorbance at 234 nm from 30 s after
addition of the enzyme, using linoleic acid (134 μM) as
substrate [51]. The final enzyme concentration was 200
U/ml. Test substances were added as DMSO solutions
(final DMSO concentration of 1.6%); DMSO alone was
added in control experiments. The enzyme solution was
kept on ice, and controls were measured at intervals
throughout the experimental periods to ensure that the
enzyme activity was constant. All measurements were
carried out in triplicate for the controls and each con-
centration of the test samples. Quercetin was employed
as a positive control. Calculation of enzyme activity was
carried out [32], and IC50 values were determined by
non-linear interpolation between the measuring points
closest to 50% activity.
Statistical Analysis
All values were expressed as mean ± SD. The sigmoidal
dose–response (variable slope) best fit EC50 for each

























Figure 2 Yield of crude extract and fractions. Mpd =Maytenus peduncu
Mun =Maytenus undata, TC = total crude, HF = hexane fraction, DCMF = dichlostandard error. The analysis was performed using
GraphPad Prism for Windows, version 5.03 (GraphPad
Software, San Diego, CA, USA). Statistical analysis of
the results was performed by using one way ANOVA,
followed by Bonferroni multiple comparison post hoc
tests and the significant difference was set at P < 0.05.
Results
Yield of extraction and fractionation
The yield of the extracts and the fractions of various
polarities using hexane, dichloromethane, ethyl acetate,
butanol and residual water are presented in Figure 2.
Maximum yield was obtained for the extracts of M.
senegalensis (37.89 ± 3.05%) followed by M. undata
(36.89 ± 4.775), while M. peduncularis (33.12 ± 1.07%)
gave the lowest yield. The extraction process efficiently
removed the chlorophyll from the bulk of the 70% acet-
one extract into the hexane portion. A part of the dried
residual water fraction could not be redissolved due to
the formation of insoluble complexes between the poly-
phenolics and other high molecular weight components
such as polysaccharides.
Antimicrobial activities of the crude extracts and fractions
The minimum inhibitory concentrations (MICs) of the
four Maytenus phenolic-enriched crude extracts and
fractions of various polarities against some enteric path-
ogens are presented in Table 2. All the crude extracts
and fractions of various polarities have antimicrobial
activities. Generally for all tested medicinal plants, the
crude extracts and polar fractions (butanol and water)
were less active than the non-polar fractions (hexane
and dichloromethane) while the intermediate polar frac-









laris, Mpr =Maytenus procumbens, Mse =Maytenus senegalensis,
romethane, ETF = ethyl acetate, BF = butanol fraction, WF =water fraction.
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good inhibitory activities the bacteria and fungi (MICs
varying from 156 to 39 μg/ml). All the bacteria were
resistant to water fraction at the highest concentration
tested but moderately sensitive to crude extract (MICs
ranging from 312to 2500 μg/ml) with E. coli and E.
faecalis being the most resistant (MIC = 2500 μg/ml).
The most susceptible bacteria were P. aeruginosa to crude
extract (625 μg/ml), hexane (39 μg/ml), dichloromethane
(78 μg/ml), ethyl acetate (156 μg/ml), Butanol (1250 μg/ml),
and S. aureus to crude extract (625 μg/ml), hexane
(78 μg/ml), dichloromethane (39 μg/ml), ethyl acetate
(156 μg/ml), butanol (625 μg/ml).
The fungi were moderately sensitive to the crude extract
(MICs ranging from 1250 to 156 μg/ml). C. neoformans
was the most sensitive fungus to dichloromethane, ethyl
acetate, butanol (MICs = 78 μg/ml), crude extract, and hex-
ane (MICs = 156 μg/ml). The non-polar fractions of M.
procumbens had the largest broad spectrum activities asTable 2 Antibacterial and antifungal activities of the crude ex
concentration (μg/ml)
Maytenus peduncularis
Microbial spp CrE Hex DCM ETOAc But
E. c 312 39 39 78 625
E. f 312 39 39 156 1250
P. a 312 19 19 156 312
S. a >2500 78 39 312 78
C. a 312 312 78 312 156
C. n 78 312 78 78 1250
A. f 312 78 156 156 312
Maytenus senegalensis
Microbial spp CrE Hex DCM ETOAc But
E. c 2500 78 78 156 1250
E. f 2500 39 39 312 625
P. a 625 39 78 156 1250
S. a 625 78 39 156 625
C. a 1250 78 39 156 156
C. n 156 156 39 78 78
A. f 625 156 78 156 1250
Microbial spp Gent Amp B 70% ace Distilled Water
E. c 0.39 - >2500 >2500
E. f 0.78 - >2500 >2500
P. a 1.56 - >2500 >2500
S. a 0.78 - >2500 >2500
C. a - 6.25 >2500 >2500
Microbial spp Gent Amp B 70% ace Distilled Water
E. c 0.39 - >2500 >2500
N.B: E. c = Escherichia coli, E. f = Enterococcus faecalis, P. a = Pseudomonas aeruginosa
neoformans, A. f = Aspergillus fumigatus, Gent = gentamicin, Amp B = amphotericin B
ETOAc = ethyl acetate and But = n- Butanol.they were active against all the microorganisms investigated
with good MIC value (MIC = 39 μg/ml). E. coli, E. faecalis,
P. aeruginosa, C. albicans and C. neoformans (MIC =
39 μg/ml), and S. aureus and A. fumigatus (MIC= 78 μg/ml)
were the most sensitive to the dichloromethane fractions.
The organisms were also very sensitive to hexane fractions
(E. coli, E. faecalis, S. aureus, (MIC = 39 μg/ml), and P.
aeruginosa and A. fumigatus (MIC = 78 μg/ml)), C. albicans
and C. neoformans (MIC = 156 μg/ml), the crude extract,
ethyl acetate and butanol fractions were moderately ac-
tive (MIC ranging from 1250 to 156 μg/ml) whereas the
water fraction was less active (MIC ranging from 312 to
>2500 μg/ml). M. peduncularis had the highest inhibitory
activities obtained with its hexane and dichloromethane
fractions on P. aeruginosa (MIC = 19 μg/ml), and on E. coli
and E. faecalis (MIC = 39 μg/ml). The dichloromethane
fraction had a broad based spectrum of activity against all
tested microorganisms (MICs varying from 156 to 19 μg/ml)
with A. fumigatus being the least sensitive (MIC =tracts and the fractions expressed as minimum inhibitory
Maytenus procumbens
Water CrE Hex DCM ETOAc But Water
>2500 1250 39 39 156 1250 >2500
>2500 >2500 39 39 156 625 >2500
>2500 312 78 39 156 625 >2500
>2500 1250 39 78 312 625 >2500
312 1250 156 39 156 312 625
2500 625 156 39 156 156 2500
625 1250 78 78 78 156 625
Maytenus undata
Water CE Hex DCM ETOAc But Water
>2500 1250 312 156 156 >2500 >2500
>2500 312 156 156 312 2500 >2500
>2500 312 78 78 78 2500 >2500
>2500 625 156 156 156 312 >2500
625 1250 625 78 312 625 1250
1250 156 1250 78 78 312 2500
312 1250 625 625 156 625 625
Controls
, S. a = Staphylococcus aureus, C. a = Candida albicans, C. n = Cryptococcus
, .CrE = crude extract, Hex = hexane fraction, DCM = dichloromethane,
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all the microorganisms tested have some resistance to
crude extracts and various fractions (MICs varying from
>2500 to 312 μg/ml) except P. aeruginosa that was sen-
sitive to hexane, dichloromethane, and ethyl acetate
(MIC = 78 μg/ml), and C. neoformans to dichlorome-
thane and ethyl acetate (MIC = 78 μg/ml). Acetone so-
lution (70%), used to dissolve the plant extracts did not
have any inhibitory activity on the microbial growth.
Antioxidant assays
The phenolic-enriched extracts and fractions of various
polarities from the leaves of four Maytenus species had
strong antioxidant activities determined by the four dif-
ferent methods, namely the DPPH radical, ABTS radical,
hydroxyl ion scavenging and linoleic acid peroxidation
inhibitory activities Tables 3 and 1. For each sample,
eight concentrations between 0.5 and 250 μg/ml were
evaluated and the quantifications of the activities were
expressed by calculating the EC50. The results indicated
that the crude extracts of the four plant species have
good DPPH scavenging capacity with EC50 values of
1.88 ± 0.02, 3.56 ± 0.16, 6.71 ± 0.26 and 3.48 ± 0.09 μg/ml
followed by ethyl acetate fractions with EC50 values of
2.33 ± 0.21, 1.22 ± 0.15, 9.50 ± 0.11and 4.55 ± 0.31 μg/ml
for M. peduncularis, M. procumbens, M. senegalensis
and M. undata respectively. Hexane and water fractions
were inactive with EC50 values greater than 110.70 ±
10.69 respectively for all the four plant species. The
control compounds were trolox and ascorbic acid with
EC50 values of.1.18 ± 0.06 and 1.50 ± 0.06 μg/ml respect-
ively. For the ABTS radical decolourization, scavengingTable 3 Free radical scavenging activities of the Maytenus spe
Mayten
Assay Crude Hex DCM
DPPH 1.88 ± 0.02 113.13 ± 12.63 28.19 ± 4.14
ABTS 8.65 ± 0.13 114.64 ± 25.93 33.54 ± 1.29
OH 23.92 ± 2.28 110.54 ± 17.91 122.07 ± 20.50
Mayten
DPPH 3.56 ± 0.16 110.70 ± 10.69 30.67 ± 4.54
ABTS 4.03 ± 0.19 277.80 ± 16.14 22.26 ± 1.36
OH 107.69 ± 12.32 179.70 ± 41.17 223.96 ± 42.04
Mayten
DPPH 6.71 ± 0.26 251.43 ± 29.54 121.27 ± 10.99
ABTS 5.34 ± 0.39 312.75 ± 43.83 139.90 ± 13.65
OH 146.30 ± 21.60 187.40 ± 55.56 356.80 ± 37.39
May
DPPH 3.48 ± 0.07 160.50 ± 31.40 42.91 ± 6.16
ABTS 7.89 ± 0.31 268.30 ± 7.78 55.30 ± 5.09
OH 80.68 ± 2.9 284.36 ± 27.04 311.90 ± 150.33
CrE = crude extract, Hex = hexane fraction, DCM = dichloromethane, ETOAc = ethyl a
ABTS = 2,2’-azino-bis 3-ethylbenzothiazoline-6-sulfonic acid, OH = hydroxyl radical.patterns were similar to that of DPPH, although the
EC50 values were comparatively lower in the ABTS assay
for all corresponding test samples. Crude extracts of the
four plants had good DPPH scavenging activity with
EC50 values of 8.65 ± 0.13, 4.03 ± 0.19, 5.34 ± 0.39 and
7.89 ± 0.31 μg/ml followed by ethyl acetate fractions with
EC50 values of 6.34 ± 0.18, 1.71 ± 0.13, 3.59 ± 0.06 and
6.66 ± 1.54 μg/ml for M. peduncularis, M. procumbens,
M. senegalensis and M. undata respectively. For butanol
fractions, the EC50 values were as follows: 52.79 ± 14.44,
8.89 ± 2.86, 7.78 ± 3.13, and 5.74 ± 1.37 μg/ml for M.
peduncularis, M. procumbens, M. senegalensis, and M.
undata respectively. . The variation in the ABTS and
DPPH radical scavenging activity of the butanol fractions
may be due to differences in antiradical mechanisms.
The efficiency of an antioxidant component to reduce
DPPH largely based on a hydrogen atom mechanism
while the ABTS assay is based on an electron transfer
mechanism with faster reaction kinetics [52]. The radical
scavenging activity of an extract depends on the quality
of the active components rather than the quantity, espe-
cially the presence of hydroxyl groups and their position.
The scavenging capacities of the extracts on hydroxyl
radical inhibition by the salicylic acid oxidation method
expressed as EC50 are presented in Table 3. Crude ex-
tract of the four plants have good OH radical scavenging
power with EC50 values of 23.92 ± 2.29, 107.69 ± 12.32,
146.30 ± 21.60 and 80.68 ± 2.90 μg/ml followed by buta-
nol fractions with EC50 values of 49.55 ± 5.70, 46.79 ±
12.42, 30.81 ± 1.78 and 51.19 ± 5.30 μg/ml for M.
peduncularis, M. procumbens, M. senegalensis and M.
undata respectively. For ethyl acetate fractions, the EC50cies expressed as EC50 (μg/ml)
us peduncularis
ETOAc But Water Trolox
2.33 ± 0.21 59.91 ± 8.01 153.40 ± 20.62 1.18 ± 0.06
6.35 ± 0.18 52.79 ± 14.44 74.89 ± 2.84
70.86 ± 18.09 49.55 ± 5.7
us procumbens
1.22 ± 0.15 20.64 ± 0.90 189.00 ± 7.56 1.20 ± 0.06
1.71 ± 0.13 8.99 ± 2.86 130.70 ± 15.06
76.70 ± 11.58 46.79 ± 12.42
us senegalensis
9.50 ± 0.11 48.10 ± 0.26 162.17 ± 22.77 1.28 ± 0.07
3.59 ± 0.06 7.78 ± 3.13 62.86 ± 3.97
42.06 ± 12.90 30.81 ± 1.78
tenus undata
4.55 ± 0.31 15.86 ± 0.31 607.30 ± 7.57 1.31 ± 0.07
6.66 ± 1.54 5.74 ± 1.37 220.27 ± 30.15
155.53 ± 35.85 51.19 ± 5.30
cetate and But = n- Butanol, DPPH. = 2, 2-Diphenyl-1-picrylhydrazyl radical,
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12.90, and 155.53 ± 35.85 μg/ml for M. peduncularis, M.
procumbens, M. senegalensis, and M. undata respectively.
All crude leaf extract of the four plant species led to dose-
dependent lipid peroxidation of linoleic acid induced
by FeSO4-H2O2 system, which was monitored by the
generation of malonydialdehyde MDA. The results
expressed as EC50 are presented in Table 1. The EC50
values were 39.84 ± 5.52, 34.21 ± 1.63, 27.21 ± 2.3, and
33.70 ± 0.85 μg/ml for M. peduncularis, M. procumbens,
M. senegalensis, and M. undata respectively. M. senegalensis
was the most active while M. peduncularis was the least
active among the extracts.
Cytotoxicity
The cytotoxicity of the phenolic-enriched crude extracts
of the four Maytenus species is presented in Table 1.
The results indicate that the extracts are relatively non-
toxic to Vero cell lines with IC50 values of 89.41 ± 16.80,
187.71 ± 19.92, 87.82 ± 3.02, and 99.17 ± 11.88 μg/ml for
M. peduncularis, M. procumbens, M. senegalensis, and
M. undata respectively. In categorizing plant extract
safety, IC50 values of 20 μg/ml and below were consid-
ered to be toxic [53]. Therefore, all the phenolic-
enriched extracts of the four Maytenus species showed
no preliminary indication of toxicity although in vivo
studies would need to confirm their safety for use in
treating diarrhoea.
Phenolic constituents
The phenolic constituents of the crude extract of
Maytenus species evaluated in this study varied widely





















Figure 3 Phenolic compositions of the acidified 70% acetone leaf ext
Mse =Maytenus senegalensis, Mun =Maytenus undata, TP (Total phenolic (m
CT (Condensed tannin (mg CE/g)), PA (proanthocyanidin (mg LE)), GT (gallo
(mg QE/g)).the extracts ranged from 112.41 ± 1.51 to 197.44 ±
2.68 mg GAE/g plant material while the total tannin
content ranged from 81.25 ± 2.66 to 1431.49 mg GAE/g
plant material. M. senegalensis contained the highest
content of total phenolics (197.44 ± 2.68 mg GAE/g
dried plant material), total tannin (143.10 ± 1.49 mg
GAE/g dried plant material), condensed tannin (35.29 ±
0.58), and proanthocyanidin (54.33 ± 2.01 mg. LE/g plant
material) while M. procumbens contained the highest
level of gallotannin (12.59 ± 3.80 mg GAE/g dried plant
material) and flavonol (17.85 ± 0.19 mg QE/g plant ma-
terial). The flavonoid content was however highest in M.
peduncularis (77.45 ± 1.43 mg QE/g plant material). The
enrichment of phenolic constituents in the extracts
depends on the extracting solvent and the process of
simultaneous extraction with acidified acetone solution
and fractionation with n-hexane was effective in this
regard. The hexane probably removed all components
such as chlorophyll, waxes and terpenoids from the
water fraction efficiently. The statistical analyses of the
phenolic constituents indicated the presence of a
good correlation between DPPH radical scavenging
ability and total phenolic (R2 = 0.8826), non-tannin
phenolic (R2 = 0.7110), total tannin (R2 = 0.9241) and
proanthocyanidin (R2 = 0.6995) content. The same
correlation was observed between the ABTS radical
scavenging ability and total phenolic (R2 = 0.8768), non-
tannin phenolic (R2 = 0.7016), total tannin (R2 = 0.9189)
and proanthocyanidin (R2 = 0.6792) content. On the other
hand, a low correlation was obtained between gallotannin
(R2 = 0.2166), flavonoid (R2 = 0.4555) and flavonol
(R2 = 0.3268) content and DPPH radical scavenging ability.














racts. Mpd =Maytenus peduncularis, Mpr =Maytenus procumbens,
g GAE/g)), TT (Total tannin (mg GAE/g)), NT (Non-tannin (mg GAE/g)),
tannin (mg GAE/g)), FT (total flavonoid (mg QE/g)), FLL (flavonol
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flavonoid (R2 = 0.4632) and flavonol (R2 = 0.3014) content.
Soybean 15-lipoxygenase inhibition
The extracts of the four Maytenus species tested
for in vitro inhibition of the enzyme soybean 15-
lipoxygenase had varying activity presented as LL50
and percentage inhibitions in Table 1 and Figure 4 re-
spectively. The most active extract was obtained from
M. peduncularis with LL50 value of 44.16 ± 5.60 μg/ml
followed by M. undata with LL50 of 50.92 ± 25.70 μg/
ml. The activity of the extracts was concentration-
dependent and the percentage inhibition ranged from
61.55 ± 4.19 μg/ml in M. peduncularis to 53.18 ±
2.30 μg/ml in M. senegalensis at the highest concentra-
tion of 256 μg/ml and 42.15 ± 4.29 μg/ml in M.
peduncularis to 34.63 ± 2.55 μg/ml in M. procumbens
at the lowest concentration of 16 μg/ml of the extracts.
Discussion
Several therapeutic procedures have been used in ortho-
dox medicine to treat diarrhoea symptoms, and associ-
ated complications. These include administration of oral
rehydration therapy (ORT) as supportive therapy, use of
antimicrobial drugs, anti-diarrhoeal agents (spasmolytic,
motility, pro-absorptive or antisecretory) as symptomatic
therapy and the use of probiotics (valuable in the treat-
ment of rotavirus infections and post antibiotic diar-
rhoea) [54]. In traditional medicine, medicinal plants
that contain a wide range of phytochemicals may exertFigure 4 Concentration-dependent percentage inhibition of soybean
Mpr =Maytenus procumbens, Mse =Maytenus senegalensis, Mun =Maytenusan effect on more than one of the aspects listed above.
The synergistic effects of the various medicinal proper-
ties may be responsible for the efficacy of plant prepara-
tions as antidiarrhoeal agents. However, the usefulness
of medicinal plants in curing diarrhoea depends on the
use of appropriate extractants. Two extractants such as
water (decoction or infusion) and less frequently alco-
holic solutions (tinctures) are mostly used in traditional
medicines. Of equal importance is the dosage of the me-
dicinal plant preparation administered to patients as ap-
plicable in conventional medicine.
Low MIC values indicate potentially high efficacy of the
extracts as antimicrobial agents [55,56]. In our laboratory,
crude extracts and fractions with an MIC <100 μg/ml are
usually regarded as pharmacologically interesting and
promising material for further studies.
The fractionation procedure used in this study potenti-
ated the antimicrobial activities of the leaf extracts in
the hexane and dichloromethane fractions with MICs
ranging from 39 to 156 μg/ml against all the organisms
tested. The intermediate polarity fraction of ethyl acetate
and butanol fraction had moderate antimicrobial activ-
ities with MICs ranging from 312 to 2500 μg/ml. Crude
extracts and water fractions had moderate to poor anti-
microbial activities with MICs ranging from 312 to
2500 μg/ml. However, some fractions had no microbial
growth inhibition at the highest concentration of
2500 μg/ml used in this study.
Neither Gram negative nor Gram positive bacteria
were highly sensitive to the crude extracts and residual15-lipoxygenase enzyme. Mpd =Maytenus peduncularis,
undata.
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bial compounds of Maytenus extracts are non-polar in
nature. Therefore, in the treatment of infectious GIT
including diarrhoea with leaf extracts of these plant
species, the use of aqueous decoctions or infusions
(polar extracts) which is the practice in traditional
medicine may not be effective except where other anti-
diarrhoeal mechanisms are involved or if some nonpolar
compounds were dissolved by microbial action during
storage of concoctions. Absence of good antimicrobial
activity from crude extracts and water fractions of all the
four plants however, does not rule out the presence of
such activity, but the phytoconstituents may be occur-
ring in low ineffective concentrations. Many of the
extracts and fractions were not highly active against
microbes tested in this work. However, they may still be
useful against infectious diseases since other mecha-
nisms in healing process involving immuno-stimulatory
[57,58] and toxin-deactivating activities [59], molecular
changes of compound from inactive to active may take
place during the digestive process, and uptake and me-
tabolism. Some antibiotics, such as macrolides, sulfon-
amides and tetracyclines, exert their pharmacological
effect by inhibiting the logarithmic growth of the bacter-
ial organism, letting the immune system fight the
infection and relieving the symptoms [60]. The pharma-
cological effect is not always related either to a bacteri-
cidal or to a bacteriostatic effect, but could be due to the
inactivation of bacterial virulence factors.
Antimicrobial, anti-inflammatory and cytotoxicity of
ethanol root extracts of M. senegalensis have been reported
[24,25]. Maytenonic acid (3-oxofriedelan-20α-oic acid)
(antibacterial activity against Bacillus subtilus (98 μg/ml),
Escherichia coli (98 μg/ml), Klebsiella pneumonia
(98 μg/ml) and Staphylococcus aureus (195 μg/ml))
[61] and pristimerin (antiplasmodial) [62] have been
isolated from methanol root extract of M. senegalensis.
Though this study did not establish the anti-infectious
effect of leaf extracts from Maytenus species against all
multitudes of microbes involve in GIT disorders, but they
have demonstrated good potential as source of novel
antimicrobial agents for the treatment of intestinal
bacterial and fungal infections.
Oxidative stress and inflammatory damage of the GIT
play an important role in initiating and maintaining diar-
rhoea symptoms. Oxidative species react with the muco-
sal epithelial membrane phospholipids to initiate and
propagate the lipid peroxidation (LPO) process causing
intestinal injury and cellular malfunction [63]. The pro-
ducts of lipid peroxidation include malondialdehydes,
4-hydroxyl-2, 3-nonenal, 4-hydroxy-2-hexenal and acro-
lein are cytotoxic [64]. In addition, the effects of LPO
are also involved in the release of inflammatory media-
tors like cytokines, eicosanoids and generation of morereactive species [65]. Oxidative species such as hypo-
chlorous acid, chloramine and some inflammatory medi-
ators like prostaglandin E act directly as secretagogues
in secretory or inflammatory diarrhoea [66]. An injured
gastrointestinal tract (GIT) from lipid peroxidation also
results in intestinal digestion and absorption disorders
causing osmotic diarrhoea. Medicinal plants with good
antioxidative or anti-inflammatory activities can be used
as supportive therapy in diarrhoeal disease to reduce the
oxidative damage to tissue cells.
The hexane, dichloromethane and water fractions had
low antioxidant activities suggesting that their chemical
components are extremely weak hydrogen or electron
donors. However, antioxidant activities of the four plants
were potentiated in the crude extracts, ethyl acetate and
butanol fractions. Differences in antioxidant activity
between the various solvents may due to variation in
polyphenol concentration extracted. Different solvents
have different degrees of solubility depending on their
polarity [67].
Acetone and ethanol leaf extracts of M. procumbens have
been reported to have anticancer and antioxidant proper-
ties. Two bioactive compounds, namely, 30-hydroxy-11a-
methoxy-18b-olean-12-en-3-one and asiatic acid have been
isolated from the extract [22]. Radical scavenging activity
potential of Maytenus species observed in this study was a
promising outcome for possible control of many oxidative
stress-related diseases. The leaf extracts from the four
plants worked better as antiradical agents than as lipid
peroxidation inhibitors, although high antioxidant activity
was obtained using all the assays.
Almost all diseases are characterized by the inflammation
and pain in response to different conditions like injuries
and infection indicate the presence of cyclooxygenase and
lipoxygenase (LOX). The lipoxygenase (LOX) inhibitory
potential of the extracts of Maytenus species was de-
termined using linoleic acid peroxidation to hydrope-
roxy linoleic acid (leukotriene (LT) catalysed by soybean
15-lipoxygenase enzymes. Although, the enzyme used is
from a plant source, the activities are similar to arachidonic
acid and mammalian 15-LOX as substrates. However, there
can be some differences in primary structure and mechan-
istic pathways. LOXs are sensitive to antioxidants, and the
common mechanism of action is inhibition of lipid hy-
droperoxide formation due to scavenging of lipid oxy- or
9-lipid peroxy-radicals formed in the course of enzyme per-
oxidation. This limits the availability of lipid hydroperoxide
substrate necessary for the catalytic cycle of LOX [68].
Another mode of LOX inhibition is attained via chelation
of its non-haem bound iron or by reduction of its ferric
form [68].
Antimicrobial, anti-inflammatory, antioxidant and anti-
malarial activity of ethanol leaf extracts of Maytenus
undata (Thunb.) have been reported [23,69]. Phytochemical
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to isolation and characterization of a number of bioactive
compounds with antistaphylococcal properties. The com-
pounds include 3-oxo-11α-methoxyolean-12-ene-30-oic acid,
3-oxo-11α-hydroxyolean-12-ene-30-oic acid, 3-oxo-olean-9
(11),12-diene-30-oic acid, 3,4-seco-olean-4(23),12-diene-3,29-
dioic acid (20-epikoetjapic acid), 3,11-dioxoolean-12-ene-30-
oic acid (3-oxo-18β-glycyrrhetinic acid), koetjapic acid,
12-oleanene artifact 3-oxo-11α-ethoxyolean-12-ene-30-oic
acid [69]. The MICs of the compounds varied between
3.125-6.25 μg/ml against methicillin-resistant S. aureus,
S. aureus and P. aeruginosa [69].
Leukotrienes and other inflammatory mediators derived
from LOX oxidation of polyunsaturated fatty acids (PUFA)
are involved in intestinal smooth muscle lining contractions
in diarrhoea and allergic reactions. The concentration-
dependent inhibition of LOX by the phenolic-enriched
Maytenus extracts indicated possible modulation of LT
synthesis and therefore, the extracts can assist against
diarrhoea through this mechanism.
For medicinal plant extracts to be useful in clinical appli-
cation, the preparation should preferably be selectively
toxic to the targeted organism or interfere directly with a
specific reaction pathway. There should be no serious ef-
fect on the host cell or interference with normal physio-
logical metabolism. The phenolic-rich Maytenus species
extracts tested in this study were relatively non-toxic com-
pared to the positive control (berberine chloride). However,
in vivo acute toxicity studies are necessary to confirm
the safety level of the extracts as in vitro assay results
do not necessarily translate to in vivo activity. Effects
of long term usage of the extracts such as mutageni-
city and genotoxicity also need to be determined.
Phytochemical analyses of the crude extracts of the
Maytenus species by other authors revealed the presence
of varied quantities of phenolic compounds such as
proanthocyanidins, flavonoids, flavonols and gallotannins.
This group of compounds are important pharmacologically,
being the antioxidant derivatives of medicinal and dietary
plants. They also have other pharmacological activities such
as antimicrobial (microbicidal or microbiostatic), anti-
inflammatory, antiviral, antidiarrhoeal [70], and immune
modulatory activities. The phenolic-enriched crude extracts
and the polar fractions of the Maytenus species tested in
this study had good antioxidative activities in one or more
of the antioxidant assays relevant to inflammation and diar-
rhoeal diseases. Therefore, the antioxidant activity of the
polar fractions in combination with the potentiated anti-
microbial activity of the non-polar fractions of the four
Maytenus species may be useful as therapeutic agents
against the broad spectrum of diarrhoeal mechanisms. The
results of this study, therefore, give a scientific basis to the
use of these plants in traditional medicine as antidiarrhoeal
therapy.Conclusion
The hexane, dichloromethane and ethyl acetate fractions
had substantial antimicrobial activities against standard
strains of diarrhoeagenic pathogens. The antimicrobial
activities of these fractions coupled with the good
antioxidative activities of the polar fractions in different
oxidative mechanisms, especially diarrhoeic relevant
lipid peroxidation and hydroxyl radical inhibition may
provide relief in diarrhoea. These activities therefore
provide a scientific base for the use of these plant
species as antidiarrhoeal agents. The cytotoxicity assay
results indicated that the extracts are relatively safe, but
dosage still needs to be monitored in order to not
exceed the toxicity level of the extracts. Other antidiar-
rhoeal mechanisms such as spasmolytic, antisecretory,
antimotility and pro-absorption properties of the ex-
tracts may also have to be investigated so as to establish
the actual mechanisms of action.
In many cases the ethyl acetate fraction had the
highest antibacterial and antioxidant activities. If the
safety of these fractions can be confirmed and there are
no bioavailability or stability problems, these fractions
may be developed into potentially useful therapeutic
products to treat diarrhoea in production animals.Abbreviations
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